[Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU]. / Tratamiento del cáncer digestivo avanzado con fluoracilo y metil - CCNU.

We relate the experience obtained by treatment of 20 advanced digestive cancer patients, with the association of 5 fluorouracil and methyl-C.C.N.U. Objective response was found in 4 patients (20%). Toxicity consisted of leucopenia in 3 patients, allergic phenomena in 2 and diarrhea in 1 patient. Mean survival is increased in 3 months in responders, when compared with non-responders, although this difference has not statistical value.